Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Vera Therapeutics Inc’s stock clocked out at $29.19, up 1.39% from its previous closing price of $28.79. In other words, the price has increased by $1.39 from its previous closing price. On the day, 0.74 million shares were traded. VERA stock price reached its highest trading level at $29.19 during the session, while it also had its lowest trading level at $28.5.
Ratios:
To gain a deeper understanding of VERA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.92 and its Current Ratio is at 16.92. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.16.
On February 04, 2025, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $49.Wolfe Research initiated its Outperform rating on February 04, 2025, with a $49 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 23 ’25 when ENRIGHT PATRICK G bought 209,393 shares for $20.87 per share. The transaction valued at 4,369,676 led to the insider holds 3,569,522 shares of the business.
ENRIGHT PATRICK G bought 40,607 shares of VERA for $907,635 on Jun 24 ’25. The Director now owns 3,596,593 shares after completing the transaction at $22.35 per share. On Feb 21 ’25, another insider, Fordyce Marshall, who serves as the PRESIDENT AND CEO of the company, sold 10,613 shares for $27.89 each. As a result, the insider received 296,032 and left with 213,740 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 1863012736 and an Enterprise Value of 1383737728.
Stock Price History:
The Beta on a monthly basis for VERA is 1.23, which has changed by -0.28525954 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $51.61, while it has fallen to a 52-week low of $18.53. The 50-Day Moving Average of the stock is 25.39%, while the 200-Day Moving Average is calculated to be 8.71%.
Shares Statistics:
It appears that VERA traded 1.49M shares on average per day over the past three months and 1655330 shares per day over the past ten days. A total of 63.82M shares are outstanding, with a floating share count of 48.53M. Insiders hold about 23.96% of the company’s shares, while institutions hold 89.01% stake in the company. Shares short for VERA as of 1757894400 were 9358966 with a Short Ratio of 6.30, compared to 1755216000 on 7770438. Therefore, it implies a Short% of Shares Outstanding of 9358966 and a Short% of Float of 16.900000000000002.
Earnings Estimates
. The current market rating for Vera Therapeutics Inc (VERA) reflects the collective analysis of 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$1.06, with high estimates of -$0.79 and low estimates of -$1.24.
Analysts are recommending an EPS of between -$3.73 and -$4.47 for the fiscal current year, implying an average EPS of -$4.12. EPS for the following year is -$4.33, with 6.0 analysts recommending between -$3.1 and -$5.42.
